You can buy or sell IQVIA Holdings and other stocks, options, ETFs, and crypto commission-free!
IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. Read More The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Yahoo FinanceMay 13
IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of this life sciences segment from concept-to-market IQVIA™ (IQV) today announced the launch of IQVIA MedTech and its dedicated industry focused solutions and services for the medical device and in vitro diagnostics market, and for companies with combination products. IQVIA MedTech empowers companies to orchestrate oper...
Associated PressMay 7
IQVIA Announces Pricing of Offering of Senior Notes
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--May 7, 2019--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,100,000,000 in aggregate principal amount of senior notes due 2027 (the “notes”). The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general cor...
Markets InsiderMay 7
United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives
HENDERSON, Nev., May 07, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that IQVIA has completed its independent market assessment of certain market opportunities for HemoStyp. This survey used a combination of interviews, market data and product usage reports to create a detailed outlook for HemoStyp’s revenue potential assuming, among o...
Expected Jul 23, Pre-Market